Lung Cancer Update

Dr. Neil Love

Non-Small Cell Lung Cancer

Immunotherapy

Lung Cancer

Small Cell Lung Cancer

Chemotherapy

Pembrolizumab

EGFR

Targeted Therapy

Osimertinib

EGFR Mutations

Antibody-Drug Conjugates

Clinical Trials

Adjuvant Therapy

Neoadjuvant Chemotherapy

EGFR Mutation

Adora Trial

Alk-Targeted Therapy

Nivolumab

Pd-L1 Expression

Antibody Drug Conjugates

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

47 ratings

Publishes	Monthly	Episodes	359	Founded	20 years ago
Number of Listeners		Categories	Health & FitnessScienceMedicine

Listen to this Podcast

Guests Host Reviews Charts Talking Points

Latest Episodes

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

Featuring an interview with Prof Martin Reck, including the following topics:

• Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbine... more

18 Jun 2026 • 40 min

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the management of SCLC.

CME i... more

9 Jun 2026 • 58 min • Most popular

Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer.

CME information and select publications here.

17 Apr 2026 • 27 min

Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy

Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial data in the first-line management of ES-SCLC, real-world case studies and... more

27 Feb 2026 • 59 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Gastrointestinal Cancer UpdateDr. Neil Love

Two Onc DocsSam and Karine

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Lung Cancer ConsideredIASLC

Breast Cancer UpdateDr. Neil Love

Recent Guests

Christine Hann

Faculty at Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine in Baltimore

Johns Hopkins University School of Medicine

Episode: Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr. Natalie Vokes

MD Anderson Cancer Center physician

MD Anderson Cancer Center

Episode: Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Hossein Borghaei

Medical oncologist; Fox Chase Cancer Center

Fox Chase Cancer Center

Episode: Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy

Anne Chiang

Medical oncologist; Yale Cancer Center

Yale Cancer Center

Episode: Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy

Aaron Lisberg

Medical Oncologist at the University of California, Los Angeles

University of California, Los Angeles

Episode: Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Dr. Aaron Lisberg

Medical oncologist from the University of California, Los Angeles

University of California, Los Angeles

Episode: Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Dr. Jacob Sands

Medical oncologist at Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Episode: Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Ben Levy

Professor at Johns Hopkins Sidney Kimmel Cancer Center

Johns Hopkins Sidney Kimmel Cancer Center

Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr. Justin Gainor

Medical Oncologist at Massachusetts General Hospital

Massachusetts General Hospital

Episode: First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

Host

Dr. Neil Love

Host of the series; Medical Oncologist with a focus on thoracic oncology and ongoing clinical discussions.

Reviews

4.6 out of 5 stars from 47 ratings

Medicine resident subscriber
Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.
Apple Podcasts
5
MG2MD
United States8 years ago
Heldere informatie over longkanker
Hier ben ik heel blij mee.
Ik wou dat zoiets in het Nederlands bestond.
Apple Podcasts
5
Thea 1953
Netherlands14 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some listeners benefit from real-world perspectives on trial data and treatment sequencing.

Listeners praise expert interviews and practical clinical insights that help translate complex literature into patient care.

The show is seen as a reliable source for nuanced discussions on targeted therapies and biomarkers.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#47	United Arab Emirates/Science
Apple Podcasts	#164	Singapore/Science
Apple Podcasts	#248	Mexico/Science

Talking Points

Recent interactions between the hosts and their guests.

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Q: What is your current approach to prophylactic cranial irradiation in limited versus extensive stage disease given newer data and imaging strategies?

The panel acknowledges evolving data, with some leaning away from routine PCI in extensive stage and others awaiting MagFrick data in limited stage to determine net benefit versus toxicity, while emphasizing patient-specific discussion with radiation oncologists.

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Q: What are your thoughts on whether PD-1 and PD-L1 inhibitors should be explored further in limited and extensive stage small cell lung cancer and how they might fit into treatment paradigms?

The guests discuss that PD-1 and PD-L1 inhibitors appear relatively similar in extensive-stage disease, suggesting they could both be viable in future trials, and that there remains potential for exploring their roles in various combinations, while noting the need to interpret tail-risk and long-term outcomes beyond median results.

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Q: So Christine, any thoughts about how you as an investigator try to keep up to date with what's going on?

Christine emphasizes the challenge of staying current across multiple cancer types, highlighting grand rounds and annual updates as practical methods to track rapidly evolving immunotherapy and targeted therapy data, while recognizing the need to continually synthesize cross-disciplinary insights.

Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Q: What about the role of ctDNA after neoadjuvant therapy in guiding post-surgical decisions, such as continuation of immunotherapy or addition of other agents?

Post-neoadjuvant ctDNA positivity may identify patients who would benefit from continued or intensified therapy (e.g., immunotherapy) even if radiographic/pathologic responses look favorable, whereas ctDNA clearance often implies better outcomes and could support de-escalation in select cases.

Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Q: Could you think of a situation, again, with localized disease, a patient who doesn't have any driver mutations, where you would currently usually not offer adjuvant chemotherapy, but you would if the patient's CT DNA were positive?

If a patient has high-risk features after resection (e.g., extensive smoking history, high PD-L1, large tumor with lymphovascular invasion), a positive CT DNA result could push toward adjuvant therapy to maximize potential cure, since MRD positivity signals higher relapse risk and could tip the balance in favor of systemic treatment.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Update

What is Lung Cancer Update about and what kind of topics does it cover?

A physician-led interview series that translates cutting-edge thoracic oncology research into practical insights for patient care. Conversations consistently cover tumor biology, targeted therapies, immunotherapy, and emerging diagnostic tools, with real-world clinical decision-making, trial data, and management of treatment-related toxicities highlighted across episodes. Notable strengths include deep clinical expertise from renowned oncologists, practical guidance for implementing new therapies, and a willingness to tackle complex, nuanced cases in NSCLC and SCLC. Listeners are likely clinicians seeking up-to-date treatment strategies and evidence-informed perspectives, as well as researchers looking for synthesis of trial data and transl... more

Where can I find podcast stats for Lung Cancer Update?

Rephonic provides a wide range of podcast stats for Lung Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Update?

Rephonic provides comprehensive predictive audience data for Lung Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Update have?

To see how many followers or subscribers Lung Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Update?

These podcasts share a similar audience with Lung Cancer Update:

1. Gastrointestinal Cancer Update
2. Two Onc Docs
3. ASCO Daily News
4. Lung Cancer Considered
5. Breast Cancer Update

How many episodes of Lung Cancer Update are there?

Lung Cancer Update launched 20 years ago and published 359 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Update?

Rephonic pulls ratings and reviews for Lung Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Update?

Rephonic provides full transcripts for episodes of Lung Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Update?

Recent guests on Lung Cancer Update include:

1. Christine Hann
2. Dr. Natalie Vokes
3. Hossein Borghaei
4. Anne Chiang
5. Aaron Lisberg
6. Dr. Aaron Lisberg
7. Dr. Jacob Sands
8. Ben Levy

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days